BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Imnovid® (pomalidomide): Hepatitis B virus status to be clarified prior to beginning treatment

Active substance: pomalidomide

The company Celgene is circulating information that in rare cases a hepatitis B re-activation occurred in patients who received pomalidomide in combination with dexamethasone and had previously become infected with the hepatitis B virus (HBV).

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 646KB, File is accessible